glutathione and the liver Dysregulation of synthesis in disease Frontiers | Glutathione: Pharmacological aspects

Nilotinib is approved under the brand name Tasigna, which is owned and marketed by Novartis, and is indicated for Philadelphia chromosome-positive chronic myeloid leukemia

Change 5 , 132137 (2015)

J Intensive Med

While glutathione deficiency is often acquired due to factors like ageing, poor nutrition, or certain medical conditions, there is evidence to suggest that genetic factors can contribute to congenital glutathione deficiencies

Technological Innovative Aspects The link between GSH and CLA allows the stabilization of the GSH highly reactive thiol unity (responsible of its known anti-oxidant action) through CLA steric hindrance around the thiol functional moiety